# Enveric Biosciences, Inc.: Form 8-K, filed May 30, 2023

- Company: [Enveric Biosciences, Inc.](/companies/envb.md) (CIK 890821)
- Form: 8-K
- Filed: 2023-05-30
- Accepted by EDGAR: May 30, 2023, 08:00 ET
- Period: 2023-05-30
- Accession: 0001493152-23-019398
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890821/000149315223019398/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890821/000149315223019398/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/890821/000149315223019398/form8-k.htm

Filed May 30, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-019398. Last ingested by Listed: Nov 14, 2026, 20:02 ET. No prices; not investment advice.
